How much is Biomatter worth in 2026?

Biomatter has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Biomatter raised?

Biomatter has raised N/A in total funding across 2 funding rounds.

Biomatter

Biotechnology

Biomatter valuation and funding history | Last updated: August 5, 2024 | 2 funding rounds

Current Valuation

N/A

As of August 5, 2024

Total Funding Raised

N/A

Across 2 rounds

Last Round

Seed Round

$7.1M

Last Funding

Aug 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 5, 2024	Seed Round	$7.1M	N/A	-
March 7, 2023	Seed Round	$1.2M	N/A	-

Valuation Analysis

Current Valuation Metrics

Biomatter is currently valued at N/A as of August 5, 2024.

Track Biomatter Valuation Updates

Get notified when Biomatter raises new funding or valuation changes

Explore More Data

Detailed analysis for Biomatter

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Biomatter's valuation history, funding rounds, and growth metrics.

No credit card required

What is Biomatter Worth in 2026?

Biomatter is a leading private company in the Biotechnology sector. Track Biomatter's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Biomatter Valuation is Determined

Private company valuations like Biomatter's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.